CRC
UTHR icon

Curi RMB Capital’s United Therapeutics UTHR Stock Holding History

Curi RMB Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Sell
935
-111
-11% -$62.5K 0.01% 600
2026
Q1 		$620K Sell
1,046
-318
-23% -$158K 0.01% 544
2025
Q4 		$665K Buy
+1,364
New +$635K 0.01% 541

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Curi RMB Capital's UTHR Position: Q2 2026 in Review

Curi RMB Capital reduced its United Therapeutics (UTHR) stake by 11% in Q2 2026, selling an estimated $62.5K and leaving 935 shares worth $507K. The position accounts for 0.01% of the portfolio, ranked #600.

Curi RMB Capital first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $665K in Q4 2025. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Curi RMB Capital held 935 shares of United Therapeutics worth $507K as of Q2 2026.
  • Curi RMB Capital sold 111 United Therapeutics shares in Q2 2026, an estimated $62.5K.
  • United Therapeutics made up 0.01% of Curi RMB Capital's portfolio in Q2 2026, its #600 holding.
  • Curi RMB Capital first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Curi RMB Capital's United Therapeutics position peaked at $665K in Q4 2025.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.